NIDA Research Studies

Spironolactone in Alcohol Use Disorder (SAUD): A double-blind, placebo-controlled, ascending dose, Phase 1b Study

Change starts here.

Drink alcohol often? You could qualify for a research study at NIDA.

A young bearded man
We are seeking study participants who are at least 21 years old and drink alcohol.
Icon - Paper Documents

Study Name

Spironolactone in Alcohol Use Disorder (SAUD): A double-blind, placebo-controlled, ascending dose, Phase 1b Study
Study# 001546-DA
Nickname: SAUD

Icon - Arrow in Target

Purpose

We are evaluating an FDA-approved drug called spironolactone. We want to understand how the body breaks down this drug and if there are any side effects in people who drink alcohol and take this drug.

Icon - Calendar and Clock

Length of Study

Four 7-day clinic stays at the NIDA Biomedical Research Center in Baltimore, MD.

Icon - Checklist

Study Activities

Taking a drug (spironolactone) and/or a placebo during visits, ETOH consumption, blood samples, and completing questionnaires.

Icon - Dollar Sign

Compensation

Completing the study can earn you up to $3,075 in compensation. If you opt-in for additional overnight stays, the compensation can reach $4,625.

Icon - Automobile

Local Travel

Will be provided (via Uber Health) or reimbursed.

Complete the online pre-screener to see if you qualify for one of our studies.

Pre-screener

Call now for a confidential screening:
 

800-535-8254

If right now isn't convenient:
 

Contact Form

More information about this study is available here.